Aclaris Therapeutics Inc (ACRS)

Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	89.29% 17.57	9.282	1.869	2.528	7.753
Cost Of Revenue	14.50% 0.725	0.848	1.042	0.808	0.877
Gross Profit	99.73% 16.84	8.434	0.827	1.72	6.876
Operating Expenses	47.78% 20.89	40.01	32.64	31.64	35.95
Benefits Costs and Expenses	52.45% 19.43	40.86	33.68	30.69	35.39
Costs And Expenses	47.09% 21.62	40.86	33.68	32.45	36.83
Operating Income/Loss	87.18% -4.047	-31.58	-31.82	-29.92	-29.08
Income/Loss From Continuing Operations Before Tax	94.12% -1.858	-31.58	-29.57	-28.16	-27.64
Income Tax Expense/Benefit	-0.367	-	-	-	-
Income/Loss From Continuing Operations After Tax	94.90% -1.491	-29.26	-29.57	-28.16	-27.64
Net Income/Loss	94.90% -1.491	-29.26	-29.57	-28.16	-27.64
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.50% 0.3564	70.81	70.63	66.87	0.4959
Diluted Average Shares	99.50% 0.3564	70.81	70.63	66.87	0.4959
Basic Earnings Per Share	95.12% -0.02	-0.41	-0.42	-0.42	-0.41
Diluted Earnings Per Share	95.12% -0.02	-0.41	-0.42	-0.42	-0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-